Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 19Genitourinary 14Gastrointestinal 14Breast 14Thoracic 7Lymphoid 6Head & Neck 6Sarcoma 5Gynecologic 5Plasma cell 4Myeloid 3Dermatologic 3Other solid neoplasm 2Endocrine 1Classical hematology 1CNS 1

Conditions

Melanoma 2Uveal Melanoma 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 194aldesleukin 148Interleukin-2 110fludarabine phosphate 106trametinib 85Temozolomide 83Dacarbazine 81fludarabine 80dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Magnetic Resonance Spectroscopy 49Aminolevulinic Acid 49binimetinib 48Carboplatin 48Specimen Handling 47Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Reverse Transcriptase Polymerase Chain Reaction × Dermatologic × Clear all
NCT00004153 2013-09-05

Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma

University of Chicago

Phase NA Completed
106 enrolled
Dermatologic

Melanoma

NCT00897624 2011-05-13

Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma

National Cancer Institute (NCI)

Completed
15 enrolled
Dermatologic

Uveal Melanoma

NCT00667901 2009-12-11

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Rutgers, The State University of New Jersey

Phase 1 Terminated
15 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡